Lawsuit Filed for Investors in Moderna, Inc. (NASDAQ: MRNA) – Contact Shareholders Foundation for Details

Investors in Moderna, Inc. (NASDAQ: MRNA) are facing a lawsuit over alleged securities laws violations. The lawsuit, filed on August 9, 2024, claims that the company misled investors about the effectiveness of mRNA-1345, leading to overstated clinical and commercial prospects. As a result, the plaintiff alleges that the company’s public statements were materially false and misleading.

Investors who purchased shares of Moderna, Inc. have certain options and deadlines to consider. The deadline for certain investors is October 8, 2024. Those affected are encouraged to contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and settlement claim filing service that provides information on shareholder issues, securities class actions, settlements, judgments, and other legal news related to the stock and financial market. It is important for investors to stay informed and take appropriate action in response to such developments in the market.

For more information and updates on this lawsuit and other related news, investors can contact the Shareholders Foundation, Inc. at the provided contact information. Stay informed and protect your investments in the ever-changing landscape of the stock market.